by Jordana Choucair | Oct 1, 2021 | Payers
HHS issued an interim final rule that outlines how dispute resolution regarding surprise billing should work between out-of-network providers and insurers. The rule states that payers and providers must start with a 30-day “open negotiation” to determine a...
by Jordana Choucair | Oct 1, 2021 | Opioid/Substance Use Disorders
• Four large pharmacy chains are set to face their first trial over the deadly U.S. opioid epidemic. Lawyers for the Ohio counties of Lake and Trumbull and companies – Walgreens Boots Alliance Inc, CVS Health Corp, Walmart Inc, and Giant Eagle Inc – are set to deliver...
by Jordana Choucair | Oct 1, 2021 | Life Sciences
Merck & Co. said its experimental antiviral pill to treat COVID-19 reduced the risk of hospitalization and death by nearly half in a clinical trial. The results prompted an independent monitoring board to recommend the study end early because of the promising...
by Jordana Choucair | Oct 1, 2021 | D.C. News
President Joe Biden signed a continuing resolution to keep the government funded through December 3. The bill, which cleared the House by a vote of 254-175 and the Senate by a vote of 65-35, gives lawmakers and the White House nine more weeks to reach agreement on...
by Jordana Choucair | Sep 30, 2021 | Payers
The CMS released the 2022 premiums for Medicare Advantage and Part D prescription drug plans. Medicare Advantage plan premiums are expected to hit $19 per month next year, a slight decline from the $21.22 in 2021. But Medicare Part D plan premiums will continue to...
Recent Comments